News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Geron Corporation
< Previous
1
2
3
4
Next >
Geron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meeting
September 07, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Participate in the Baird 2023 Global Healthcare Conference
September 05, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS
August 22, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
August 21, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 17, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results
August 03, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Announce Second Quarter 2023 Financial Results on August 3, 2023
July 27, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 20, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS
June 29, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 22, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Submission of New Drug Application to FDA for First-in-Class Telomerase Inhibitor Imetelstat
June 20, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces First Patient Dosed in Investigator-Led Phase 2 IMpress Trial Evaluating Imetelstat in Patients with Relapsed/Refractory AML or Higher Risk MDS
June 13, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces New Data and Analyses from IMerge Phase 3 Presented at EHA Reporting Robust Durability of Transfusion Independence, Evidence of Disease-Modifying Activity and Favorable Fatigue PRO in Imetelstat-Treated Lower Risk MDS Patients
June 12, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Host Virtual Investor Event on June 14, 2023
June 06, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces ASCO Presentation Reporting Durable Continuous Transfusion Independence with Imetelstat in IMerge Phase 3 Lower Risk MDS Patients
June 02, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Oral Presentation at Upcoming ASCO Annual Meeting to Highlight Meaningful Continuous Transfusion Independence Observed in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3
May 25, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3
May 11, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports First Quarter 2023 Financial Results and Business Highlights
May 11, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
May 04, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
April 26, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 20, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at Upcoming Investor Conferences in April
April 12, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 16, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
March 16, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
March 09, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
January 12, 2023
From
Geron Corporation
Via
Business Wire
Tickers
GERN
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.